Aciclovir Tablet Strengths for Cold Sore Treatment
Standard Aciclovir Dosage Strengths
Aciclovir tablets are manufactured in three primary strengths: 200mg, 400mg, and 400mg. For cold sore treatment, the 400mg strength represents the most commonly prescribed option for acute episodes. The 200mg tablets may be utilised for suppressive therapy or when specific dosing adjustments are required. Higher strength 400mg tablets are typically reserved for other herpes virus conditions rather than cold sores.
Treatment Duration and Tablet Requirements
A typical cold sore treatment course involves taking aciclovir tablets five times daily for five days. With 400mg tablets, this equates to 2000mg total daily dose. Starting treatment during the tingling stage, before blisters appear, may help reduce outbreak severity and duration. EverydayMeds stocks aciclovir 400mg tablets suitable for standard treatment protocols.
Alternative Antiviral Tablet Options
Valaciclovir tablets offer an alternative antiviral treatment with different dosing convenience. Available in 500mg strength, valaciclovir typically requires less frequent dosing compared to aciclovir. This may suit individuals seeking simplified dosing schedules. Both medications work by inhibiting viral replication, though they differ in how the body processes them.
Factors Affecting Dosage Selection
Several factors influence appropriate tablet strength selection, including outbreak frequency, individual response to treatment, and kidney function. Patients with frequent recurrent episodes may benefit from suppressive therapy using lower daily doses. Those with reduced kidney function may require dosage adjustments. Healthcare providers consider these factors when determining optimal tablet strength and dosing schedule.
Accessing Cold Sore Treatments
EverydayMeds offers convenient access to prescription cold sore treatments including aciclovir tablets and valaciclovir alternatives. Our online consultation process enables patients to obtain appropriate treatments with proper medical oversight. Treatment options include both acute episode management and suppressive therapy for frequent sufferers.
